<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05099523</url>
  </required_header>
  <id_info>
    <org_study_id>2021/01</org_study_id>
    <nct_id>NCT05099523</nct_id>
  </id_info>
  <brief_title>Intraoperative Different Concentrations Oxygen And Oxidatıve Stress Markers</brief_title>
  <official_title>The Effects of Intraoperative Oxygen Used at Different Concentrations on Oxidatıve Stress Markers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zonguldak Bulent Ecevit University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zonguldak Bulent Ecevit University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study was to assess the effect of intraoperative oxygen (O2), which was&#xD;
      applied at 30% and 50% concentrations on patients who had undergone septoplasty surgery, on&#xD;
      Total Oxidant Status (TOS), Total Antioxidant Status (TAS), and Oxidative Stress Index (OSI).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Actual">May 30, 2021</completion_date>
  <primary_completion_date type="Actual">May 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>EFFECTS OF INTRAOPERATIVE OXYGEN USED AT DIFFERENT CONCENTRATIONS ON OXIDATIVE STRESS MARKERS</measure>
    <time_frame>end of the surgery</time_frame>
    <description>TAS and TOS values occurring at different oxygen concentrations</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Stress</condition>
  <condition>Hyperoxia</condition>
  <arm_group>
    <arm_group_label>group I</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>50%Fio2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group II</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30%Fio2</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>taking arterial blood sample through the injector</intervention_name>
    <description>taking blood samples from patients applied with different oxygen concentrations</description>
    <arm_group_label>group I</arm_group_label>
    <arm_group_label>group II</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients aged between 18-60 years,&#xD;
&#xD;
          -  ASA I-II risk class with a minimum operative time of 1.5 hour(s) for whom septoplasty&#xD;
             operation under elective conditions&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  metabolic, endocrine, hepatic, cardiac, or renal diseases,&#xD;
&#xD;
          -  malignancies and who used a drug with antioxidant properties such as vitamin E-C&#xD;
&#xD;
          -  acetylcysteine in the last 48 hours,&#xD;
&#xD;
          -  patients requiring intraoperative 100% O2 inhalation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Zonguldak Bülent Ecevit University</name>
      <address>
        <city>Zonguldak</city>
        <state>Kozlu</state>
        <zip>67600</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 8, 2021</study_first_submitted>
  <study_first_submitted_qc>October 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2021</study_first_posted>
  <last_update_submitted>October 18, 2021</last_update_submitted>
  <last_update_submitted_qc>October 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zonguldak Bulent Ecevit University</investigator_affiliation>
    <investigator_full_name>Gamze Küçükosman</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>oxidative stress markers</keyword>
  <keyword>general anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

